For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...

The firm will deliver SGT-212 to patients' brains and intravenously to try to restore frataxin levels and diminish ...

Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity.

VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a ...

Solix Technologies, Inc., a leading cloud data management and enterprise AI solutions provider, and VirtualZ Computing, a pioneer in no-code, out-of-the-box data access software, today announced a ...

Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced today a partnership with Evolyra Therapeutics to ...

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is proud to announce the launch of its new line of Alkali-Tolerant AAV Affinity Agarose Resins. Specifically ...

Detailed price information for Oxford Biomedica Plc New (OXBDF) from The Globe and Mail including charting and trades.

New expedited service line designed for biotechs with timeline constraints, launched in response to client demandCan accelerate timeline to GMP ...

Virica Biotech (“Virica”), a cell enhancer company specializing in Viral Sensitizers (VSE™) for viral vector manufacturing, today announced it is receiving advisory services and funding from the ...